{{'Tue, 10 Jun 2025 08:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk to present array of new portfolio data including studies with semaglutide and CagriSema, expanding evidence in obesity and diabetes care at ADA 2025
Read more
{{'Fri, 06 Jun 2025 09:10:00 -0400' | dateFormatUsFilter}}
Novo Nordisk to present phase 3 trials across hemophilia portfolio, reinforcing commitment to research in rare blood disorders, at ISTH 2025
Read more
{{'Tue, 03 Jun 2025 10:00:00 -0400' | dateFormatUsFilter}}
The Obesity Association and Novo Nordisk Inc. are Changing the Conversation on Obesity
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.